Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion type Assertion NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_head.
- NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion wasGeneratedBy ECO_0000203 NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_provenance.
- NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion wasDerivedFrom befree-2016 NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_provenance.
- NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion SIO_000772 20582464 NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_provenance.
- NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion evidence source_evidence_literature NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_provenance.
- NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_assertion description "[In conclusion, a promising defective DNA repair gene expression signature appears to differentiate TN breast cancers that are sensitive to anthracyclines and resistant to taxane-based chemotherapy, and should be tested in clinical trials with other DNA-damaging agents and PARP-1 inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP821862.RAByWudtd4HMZLUOeN6jlOyih7KstTFC6kKeU-xWmrDI8130_provenance.